COURT-RULING filed Apr 21, 2026 at 20:00 ET
The court denied plaintiffs' motion for sanctions against Abbott and denied their request to reopen discovery in this infant formula product liability case. The court granted only limited post-discovery production of Abbott's written response to the FDA's 2022 Establishment Inspection Report and a brief supplemental briefing schedule on Abbott's pending summary judgment motion. The ruling is a modest procedural win for Abbott: the case remains alive but plaintiffs were denied the broad discovery expansion they sought, and the core summary judgment motion is still pending with near-term resolution likely.